InvestorsHub Logo
Followers 2
Posts 43
Boards Moderated 0
Alias Born 03/03/2018

Re: None

Saturday, 03/03/2018 4:43:04 PM

Saturday, March 03, 2018 4:43:04 PM

Post# of 39
Analyst Ken Kremsky has picked MNKD for long term growth. Their ground-breaking pharmeceutical pipeline is amazing.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.